Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3 , Pages 417-421 , March 2008

The Role of Botulinum Toxin Type A in the Radiation Fibrosis Syndrome: A Preliminary Report

  • Michael D. Stubblefield, MD

      Affiliations

    • Department of Neurology, Rehabilitation Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY
    • Corresponding Author InformationReprint requests to Michael D. Stubblefield, MD, Rehabilitation Medicine Service, Memorial Sloan-Kettering Cancer Center, Box 349, 1275 York Ave, New York City, NY 10021
    • ,
  • Aaron Levine, MD

      Affiliations

    • Department of Rehabilitation Medicine, New York-Presbyterian Hospital, New York, NY.
    • ,
  • Christian M. Custodio, MD

      Affiliations

    • Department of Neurology, Rehabilitation Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Theresa Fitzpatrick, PT

      Affiliations

    • Department of Neurology, Rehabilitation Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY

References 

  1. Royal MA. The use of botulinum toxins in the management of pain and headache. Phys Med Rehabil Clin N Am. 2003;14:805–820
  2. Stubblefield MD. Radiation fibrosis syndrome. In:  Cooper G editors. Therapeutic uses of Botox. Totowa: Humana Pr; 2007;p. 19–38
  3. Lou JS, Pleninger P, Kurlan R. Botulinum toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasms. Mov Disord. 1995;10:680–681
  4. Van Daele DJ, Finnegan EM, Rodnitzky RL, Zhen W, McCullock TM, Hoffman HT. Head and neck muscle spasms after radiotherapy (Management with botulinum toxin A injection). Arch Otolaryngol Head Neck Surg. 2002;128:956–959
  5. Wittekindt C, Liu WC, Klaussmann JP, Guntinas-Lichius O. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection. Head Neck. 2004;26:39–45
  6. Okereke LI, Stubblefield MD, Custodio CM. Botulinum toxin type A for radiation-induced trismus and facial pain: a case report [abstract]. Arch Phys Med Rehabil. 2004;85:E37
  7. Wittekindt C, Liu WC, Preuss SF, Guntinas-Lichius O. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study. Laryngoscope. 2006;116:1168–1171
  8. Hauer-Jensen M, Fink LM, Wang J. Radiation injury and the protein C pathway. Crit Care Med. 2004;32(Suppl):S325–S330
  9. Saarto T, Janes R, Tenhunen M, Kouri M. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain. 2002;6:323–330
  10. Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur Radiol. 1996;6:786–795
  11. Portlock CS, Boland P, Hays AP, Antonescu CR, Rosenblum MK. Nemaline myopathy: a possible late complication of Hodgkin’s disease therapy. Hum Pathol. 2003;34:816–818
  12. Johansson S, Svensson H, Larsson L, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients: a long-term follow-up. Acta Oncol. 2000;39:373–382
  13. New P. Radiation injury to the nervous system. Curr Opin Neurol. 2001;14:725–734
  14. Delanian S, Lefaix JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007;17:99–107
  15. Johansson S, Svensson H, Denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiation Oncol Biol Phys. 2000;48:745–750
  16. Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys. 1995;31:1309–1318
  17. Greenfield MM, Stark GM. Post-irradiation neuropathy. AJR Am J Roentgenol. 1948;60:617–622
  18. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve. 2005;32:431–442
  19. Mense S. Neurobiological basis for the use of botulinum toxin in pain therapy. J Neurol. 2005;251(Suppl 1):I1–I7
  20. Karuman PM, Soo KC. Motor innervation of the trapezius muscle: a histochemical study. Head Neck. 1996;18:254–258
  21. Tytherleigh-Strong G, Hirahara A, Miniaci A. Rotator cuff disease. Curr Opin Rheumatol. 2001;13:135–145
  22. Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxicon. 2000;38:245–258
  23. Durham PL, Cady R, Cady RK. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44:35–42
  24. Cui M, Li Z, You S, Khanijou S, Aoki KR. Mechanisms of the antinociceptive effect of subcutaneous BOTOX: inhibition of peripheral and central nociceptive processing [abstract]. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:R17
  25. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26:785–793
  26. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–133

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.

PII: S0003-9993(07)01815-1

doi: 10.1016/j.apmr.2007.11.022

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 3 , Pages 417-421 , March 2008

Article Tools